TrialRheumatology international2017
Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis.
Michael H Schiff et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled ittrialcites it